Skip to main content
Equibles

PFM Health Sciences, LP

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1442756 SAN FRANCISCO, CA
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,870,103
-$270,189 QoQ
Shares Held
253,358
-1.7% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#91
of 472 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Dec 31, 2024
CallValue
$1,372,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. BBIO ranks #6 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 233,171 $62,191,369
2 AXSM
Axsome Therapeutics, Inc.
 219,596 $53,750,512
3 JAZZ
Jazz Pharmaceuticals plc
 160,768 $38,740,264
4 INBX
Inhibrx Biosciences, Inc.
 308,385 $29,219,478
5 RVMD
Revolution Medicines, Inc.
 143,222 $26,822,616
6 BBIO
BridgeBio Pharma, Inc.
This page 		253,358 $18,870,103
7 CYTK
Cytokinetics Inc
 191,686 $16,329,730
8 MDGL
Madrigal Pharmaceuticals, Inc.
 29,313 $15,739,615

All Filings in BBIO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,870,103 253,358
2026-03-31 $19,140,292 257,747
2025-12-31 $23,444,643 306,506
2025-09-30 $16,993,417 327,174
2025-06-30 $22,531,021 521,793
2025-03-31 $31,394,226 908,135
2024-12-31 $7,964,240 290,242
2024-12-31 $1,372,000 50,000